#SARD #ILD Who to screen for #rheumatic #diseases For ILD #ACR guidelines Screening May also depend on ILD prevalence Not sure if frequency of screening and how to screen @jeffsparks #ORA24 @ORAexec https://t.co/BcyyYLKvr6

• https://twitter.com/Janetbirdope/status/1794450777336877479/photo/1
• https://twitter.com/Janetbirdope/status/1794450777336877479/photo/1

The original direct comparison study! https://t.co/hqrPKfNW1y

• https://twitter.com/bella_mehta/status/1800893238737527096/photo/1

https://t.co/H8TijO4UUV

• https://twitter.com/bella_mehta/status/1800894662221435004/photo/1
• https://twitter.com/bella_mehta/status/1800894662221435004/photo/1
• https://twitter.com/bella_mehta/status/1800894662221435004/photo/1

SLE RPI may be used more frequently and can connect the digital dots! @RheumNow https://t.co/UdVIyZJhJV

• https://twitter.com/bella_mehta/status/1800896319235731601/photo/1

#EULAR2024 OP0077 Please find an interview with my dear colleague @edvital on the importance of achieving and sustaining B cell depletion for improved clinical response in #lupus #SLE @RheumNow https://t.co/4rTtFWxSvs https://t.co/4esoFTsgzC

• Does B Cell Depletion Matter?
• https://twitter.com/Yuz6Yusof/status/1801126042578395601/photo/1

#EULAR2024 OP0124 EULAR recommended target oral Pred =<5mg/d. Should the threshold of LLDAS be changed to LLDAS5? Multicentre study showed the protection gained from mortality, irreversible organ damage accrual and flare was no different btw the two targets @RheumNow #EULARBEST https://t.co/GbP25tTmX8

• https://twitter.com/Yuz6Yusof/status/1801176143971647832/photo/1
• https://twitter.com/Yuz6Yusof/status/1801176143971647832/photo/1

#EULAR2024 OP0145 Can we reclassify people with ANA+ RMD to improve clinical outcomes & stratify for basket trials? Deep machine learning identified distinct classes of ANA-RMD with distinct phenotypes & predicted long-term outcomes better than the legacy diagnoses @RheumNow https://t.co/W2hmmj0v8Y

• https://twitter.com/Yuz6Yusof/status/1801179216769139144/photo/1

#EULAR2024 OP0149 When the Doctor says YES but the patients say NO. Data from UK BILAG-BR in moderate to severe #lupus showed ~half patients who met clinical response did not improve their psychological wellbeing. Factors of discordant: ancestry, damage, SLEDAI-2K @RheumNow https://t.co/9cqcPripA2

• https://twitter.com/Yuz6Yusof/status/1801182856523251734/photo/1

#EULAR2024 OP0180 Can we safely taper GC in #lupus patients who are in remission? Single study in Italy showed in pts with SLEDAI=0 + pred =<5mg/d + stable IS/HCQ, GC discontinuation after proper tapering appeared safe and was associated with a low risk of flare @RheumNow https://t.co/8IIgPuZUrF

• https://twitter.com/Yuz6Yusof/status/1801187151331156458/photo/1
• https://twitter.com/Yuz6Yusof/status/1801187151331156458/photo/1